Prognostic value of plasma atrial natriuretic factor, norepinephrine and epinephrine in acute myocardial infarction.

[1]  J. Remes.  Neuroendocrine activation after myocardial infarction. , 1994, British heart journal.

[2]  K. Swedberg,et al.  Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) , 1992, The New England journal of medicine.

[3]  T. Pindborg,et al.  Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction , 1992, British heart journal.

[4]  J. Olweus,et al.  Blood Flow Regulation During Acute Regional Ischemia in Feline Hearts: Importance of Postjunctional α1- and α1-Adrenoceptors , 1991 .

[5]  K. Dickstein,et al.  Plasma atrial natriuretic factor concentration during maximal cardiopulmonary exercise in men with mild heart failure. , 1990, International journal of cardiology.

[6]  M. Capelli,et al.  Plasma atrial natriuretic factor in patients with acute myocardial infarction. , 1990, European heart journal.

[7]  A. Takeshita,et al.  Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. , 1990, Circulation.

[8]  T. Benraad,et al.  Atrial natriuretic peptide after myocardial infarction. , 1989, American heart journal.

[9]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.

[10]  M. Kinoshita,et al.  Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. , 1989, American heart journal.

[11]  C. Johnston,et al.  Plasma atrial natriuretic peptide in patients with acute myocardial infarction: effects of streptokinase. , 1989, British heart journal.

[12]  T. Pindborg,et al.  Atrial natriuretic peptide and acute myocardial infarction. , 1989, American heart journal.

[13]  H. Tomoda.  Atrial natriuretic peptide in acute myocardial infarction. , 1988, The American journal of cardiology.

[14]  R. Dietz,et al.  Role of right and left atrial dimensions for release of atrial natriuretic peptide in left-sided valvular heart disease and idiopathic dilated cardiomyopathy. , 1988, The American journal of cardiology.

[15]  A. Rumley,et al.  Neuroendocrine activation after acute myocardial infarction. , 1988, British heart journal.

[16]  R. Zimmerman,et al.  Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. , 1988, Circulation research.

[17]  M. Schaller,et al.  Clinical and hemodynamic correlates of elevated plasma arginine vasopressin after acute myocardial infarction. , 1987, The American journal of cardiology.

[18]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[19]  E. Espiner,et al.  HAEMODYNAMIC EFFECTS OF ATRIAL PEPTIDE INFUSION IN HEART FAILURE , 1986, The Lancet.

[20]  J. Laragh,et al.  Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. , 1985, The New England journal of medicine.

[21]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[22]  R. Norris,et al.  Prognosis after myocardial infarction: results of 15 year follow up. , 1984, British medical journal.

[23]  B. Michorowski,et al.  The renin-angiotensin--aldosterone system and the clinical course of acute myocardial infarction. , 1983, European heart journal.

[24]  R. Ritz,et al.  Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severity. , 1982, Chest.

[25]  R. Rodnight,et al.  Assay of plasma catecholamines by liquid chromatography with electrochemical detection. , 1981, Analytical biochemistry.

[26]  P. Cryer,et al.  Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. , 1981, American heart journal.

[27]  C. Benedict,et al.  Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock. , 1979, British heart journal.

[28]  J W Covell,et al.  Prognosis After Acute Myocardial Infarction A Multivariate Analysis of Mortality and Survival , 1979, Circulation.

[29]  R. Shephard,et al.  Letter: Smoking and carboxyhaemoglobin levels. , 1974, Lancet.

[30]  J. Shillingford,et al.  Free noradrenaline and adrenaline excretion in relation to the development of cardiac arrhythmias and heart-failure in patients with acute myocardial infarction. , 1969, Lancet.

[31]  T. Killip,et al.  Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. , 1967, The American journal of cardiology.